| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |